OneSource Specialty Pharma Receives ESG Rating of 73 from NSE Sustainability for FY25
OneSource Specialty Pharma Limited has been assigned an ESG rating of 73 in the 'Leader' category by NSE Sustainability Ratings & Analytics Limited for FY25. The rating was assigned independently based on publicly available information, without any engagement from the company. The announcement was made through a regulatory filing under SEBI Listing Regulations on April 16, 2026.
*this image is generated using AI for illustrative purposes only.
OneSource Specialty Pharma Limited has received an Environmental, Social and Governance (ESG) rating of 73 from NSE Sustainability Ratings & Analytics Limited for the financial year FY25. The company announced this development through a regulatory filing dated April 16, 2026, submitted under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
ESG Rating Details
The ESG rating assessment resulted in the following outcome for OneSource Specialty Pharma:
| Parameter: | Details |
|---|---|
| ESG Rating Score: | 73 |
| Rating Category: | Leader |
| Assessment Period: | FY25 |
| Rating Agency: | NSE Sustainability Ratings & Analytics Limited |
Independent Assessment Process
NSE Sustainability conducted this rating exercise independently, without any engagement from OneSource Specialty Pharma. The rating agency based its assessment entirely on information pertaining to FY25 that was available in the public domain. This approach demonstrates the objective nature of the evaluation process, as the company did not initiate or participate in requesting this ESG rating.
Regulatory Compliance
The intimation was made in accordance with SEBI Master Circular no. SEBIHO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The disclosure was signed by Trisha A, who serves as the Compliance Officer and Company Secretary of OneSource Specialty Pharma Limited, with membership number A47635.
ESG Rating Significance
The 'Leader' category rating of 73 reflects OneSource Specialty Pharma's performance across environmental, social, and governance parameters. ESG ratings have become increasingly important for companies as investors and stakeholders place greater emphasis on sustainable business practices and corporate responsibility. The independent nature of this assessment by NSE Sustainability adds credibility to the rating outcome.
Historical Stock Returns for Onesource Specialty Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.07% | +9.49% | +0.88% | -18.43% | -4.78% | -11.91% |
How might this ESG 'Leader' rating impact OneSource Specialty Pharma's ability to attract ESG-focused institutional investors and potentially lower its cost of capital?
Will OneSource Specialty Pharma leverage this strong ESG rating to expand into international markets where sustainability credentials are increasingly required for pharmaceutical partnerships?
What specific ESG initiatives or improvements could OneSource implement to potentially achieve an even higher rating in the next assessment cycle?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
